LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 222

Search options

  1. Book: Updates in anxiety treatment

    Strawn, Jeffrey R.

    (Child and adolescent psychiatric clinics of North America ; volume 32, number 3 (July 2023))

    2023  

    Author's details editors Jeffrey R. Strawn, Justine Larson
    Series title Child and adolescent psychiatric clinics of North America ; volume 32, number 3 (July 2023)
    Collection
    Language English
    Size xii Seiten, Seite 486-653, Illustrationen
    Publisher Elsevier
    Publishing place Philadelphia, Pennsylvania
    Publishing country United States
    Document type Book
    HBZ-ID HT030059842
    ISBN 978-0-443-18282-2 ; 0-443-18282-5
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book ; Online ; E-Book: Promoting the emotional and behavioral success of youths

    Delgado, Sergio V. / Pedapati, Ernest V. / Strawn, Jeffrey R.

    a practical guide for clinicians

    2022  

    Author's details Sergio V. Delgado, Ernest V. Pedapati, Jeffrey R. Strawn
    Keywords Adjustment disorders in children ; Problem children/Behavior modification
    Subject code 618.9289
    Language English
    Size 1 online resource (343 pages)
    Publisher Springer
    Publishing place Cham, Switzerland
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    ISBN 3-030-88075-3 ; 9783030880743 ; 978-3-030-88075-0 ; 3030880745
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  3. Article ; Online: Response to Plöderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder".

    Strawn, Jeffrey R / Mills, Jeffrey A

    Journal of child and adolescent psychopharmacology

    2024  Volume 34, Issue 2, Page(s) 106–107

    MeSH term(s) Child ; Humans ; Adolescent ; Escitalopram ; Anxiety Disorders/drug therapy ; Selective Serotonin Reuptake Inhibitors/therapeutic use ; Double-Blind Method
    Chemical Substances Escitalopram (4O4S742ANY) ; Selective Serotonin Reuptake Inhibitors
    Language English
    Publishing date 2024-01-16
    Publishing country United States
    Document type Randomized Controlled Trial ; Multicenter Study ; Letter
    ZDB-ID 1055410-5
    ISSN 1557-8992 ; 1044-5463
    ISSN (online) 1557-8992
    ISSN 1044-5463
    DOI 10.1089/cap.2023.0089
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The Pharmacogenetic Journey in Child and Adolescent Psychopharmacology: Are We There Yet?

    Namerow, Lisa B / Strawn, Jeffrey R

    Journal of child and adolescent psychopharmacology

    2023  Volume 34, Issue 1, Page(s) 1–3

    MeSH term(s) Child ; Humans ; Adolescent ; Psychopharmacology ; Pharmacogenetics
    Language English
    Publishing date 2023-12-26
    Publishing country United States
    Document type Editorial
    ZDB-ID 1055410-5
    ISSN 1557-8992 ; 1044-5463
    ISSN (online) 1557-8992
    ISSN 1044-5463
    DOI 10.1089/cap.2023.29254.editorial
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Anxiety Disorders and Their Treatment in Youth: A New Era.

    Strawn, Jeffrey R / Larson, Justine

    Child and adolescent psychiatric clinics of North America

    2023  Volume 32, Issue 3, Page(s) xi–xii

    Language English
    Publishing date 2023-03-21
    Publishing country United States
    Document type Editorial
    ZDB-ID 1313996-4
    ISSN 1558-0490 ; 1056-4993
    ISSN (online) 1558-0490
    ISSN 1056-4993
    DOI 10.1016/j.chc.2023.03.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Socioeconomic Predictors of Treatment Outcomes Among Adults With Major Depressive Disorder: In Reply.

    Mills, Jeffrey A / Suresh, Vikram / Strawn, Jeffrey R

    Psychiatric services (Washington, D.C.)

    2023  Volume 74, Issue 2, Page(s) 215–216

    MeSH term(s) Adult ; Humans ; Depressive Disorder, Major/therapy ; Treatment Outcome ; Socioeconomic Factors
    Language English
    Publishing date 2023-02-01
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 1220173-x
    ISSN 1557-9700 ; 1075-2730
    ISSN (online) 1557-9700
    ISSN 1075-2730
    DOI 10.1176/appi.ps.23074003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond

    Stancil, Stephani L / Sandritter, Tracy / Strawn, Jeffrey R

    Journal of child and adolescent psychopharmacology

    2024  Volume 34, Issue 1, Page(s) 61–66

    Abstract: Background: ...

    Abstract Background:
    MeSH term(s) Male ; Child ; Adolescent ; Humans ; Oxcarbazepine ; Anticonvulsants/adverse effects ; Pharmacogenetics ; HLA-B Antigens/genetics ; Stevens-Johnson Syndrome/genetics
    Chemical Substances Oxcarbazepine (VZI5B1W380) ; Anticonvulsants ; HLA-B Antigens
    Language English
    Publishing date 2024-02-20
    Publishing country United States
    Document type Case Reports ; Review ; Journal Article
    ZDB-ID 1055410-5
    ISSN 1557-8992 ; 1044-5463
    ISSN (online) 1557-8992
    ISSN 1044-5463
    DOI 10.1089/cap.2023.0064
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Editorial: A Better Perspective on Antipsychotic-Related Hyperprolactinemia in Children and Adolescents.

    Strawn, Jeffrey R / Geracioti, Thomas D

    Journal of the American Academy of Child and Adolescent Psychiatry

    2023  Volume 62, Issue 9, Page(s) 967–969

    Abstract: Antipsychotic-induced hyperprolactinemia is common in children and adolescents, but this quotidian presence in our clinics should neither reassure us nor make us complacent. The report by Koch and ... ...

    Abstract Antipsychotic-induced hyperprolactinemia is common in children and adolescents, but this quotidian presence in our clinics should neither reassure us nor make us complacent. The report by Koch and colleagues
    MeSH term(s) Male ; Female ; Adolescent ; Child ; Humans ; Antipsychotic Agents/adverse effects ; Hyperprolactinemia/chemically induced ; Hyperprolactinemia/diagnosis ; Prolactin/adverse effects ; Dopamine/adverse effects ; Risperidone/therapeutic use ; Aripiprazole/adverse effects
    Chemical Substances Antipsychotic Agents ; Prolactin (9002-62-4) ; Dopamine (VTD58H1Z2X) ; Risperidone (L6UH7ZF8HC) ; Aripiprazole (82VFR53I78)
    Language English
    Publishing date 2023-05-10
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 392535-3
    ISSN 1527-5418 ; 0890-8567
    ISSN (online) 1527-5418
    ISSN 0890-8567
    DOI 10.1016/j.jaac.2023.05.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Neurobiology of Treatment in Pediatric Anxiety Disorders.

    Baumel, W Thomas / Strawn, Jeffrey R

    Child and adolescent psychiatric clinics of North America

    2023  Volume 32, Issue 3, Page(s) 589–600

    Abstract: Both pharmacologic and psychotherapeutic treatment-related changes increase activity in brain regions implicated in prefrontal regulatory circuits, and the functional connectivity of these regions with the amygdala is enhanced following pharmacological ... ...

    Abstract Both pharmacologic and psychotherapeutic treatment-related changes increase activity in brain regions implicated in prefrontal regulatory circuits, and the functional connectivity of these regions with the amygdala is enhanced following pharmacological treatment. This may suggest overlapping mechanisms of action across therapeutic modalities. The existing literature is best viewed as a partially constructed scaffold on which to construct a vigorous understanding of biomarkers in pediatric anxiety syndromes. As the field approaches leveraging "fingerprints" in neuroimaging with "outputs" in neuropsychiatric tasks and scale, we can move beyond one-size-fits-all selection of psychiatric interventions toward more nuanced therapeutic strategies that recognize individual differences.
    MeSH term(s) Humans ; Child ; Selective Serotonin Reuptake Inhibitors ; Cognitive Behavioral Therapy ; Anxiety Disorders/therapy ; Anxiety ; Brain/diagnostic imaging
    Chemical Substances Selective Serotonin Reuptake Inhibitors
    Language English
    Publishing date 2023-03-21
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural
    ZDB-ID 1313996-4
    ISSN 1558-0490 ; 1056-4993
    ISSN (online) 1558-0490
    ISSN 1056-4993
    DOI 10.1016/j.chc.2023.02.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Risk Factors for Pediatric Anxiety Disorders.

    Warner, Emily N / Strawn, Jeffrey R

    Child and adolescent psychiatric clinics of North America

    2023  Volume 32, Issue 3, Page(s) 485–510

    Abstract: This review summarizes risk factors for developing anxiety disorders in children and adolescents. A surfeit of risk factors, including temperament, family environment (eg, parenting style), environmental exposures (eg, particulate matter), and cognitive ... ...

    Abstract This review summarizes risk factors for developing anxiety disorders in children and adolescents. A surfeit of risk factors, including temperament, family environment (eg, parenting style), environmental exposures (eg, particulate matter), and cognitive factors (eg, threat bias), increases the risk of anxiety in children. These risk factors can significantly impact the trajectory of pediatric anxiety disorders. The impact of severe acute respiratory syndrome coronavirus 2 infection on anxiety disorders in children is discussed in addition to its public health implications. Identifying risk factors for pediatric anxiety disorders creates a scaffold for the development of prevention strategies and for reducing anxiety-related disability.
    MeSH term(s) Adolescent ; Humans ; Child ; COVID-19/complications ; Anxiety Disorders/epidemiology ; Anxiety Disorders/etiology ; Anxiety/psychology ; Parenting/psychology ; Risk Factors
    Language English
    Publishing date 2023-02-26
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 1313996-4
    ISSN 1558-0490 ; 1056-4993
    ISSN (online) 1558-0490
    ISSN 1056-4993
    DOI 10.1016/j.chc.2022.10.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top